March is Colorectal Cancer Awareness Month, a time dedicated to raising awareness about one of the most preventable yet still highly prevalent cancers in the United States.
According to the American Cancer Society, colorectal cancer remains the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths among men and women combined. Despite these sobering statistics, colorectal cancer is uniquely positioned for effective prevention through routine screening and early intervention.
The Role of Pharmacies
Pharmacies play a critical frontline role in advancing awareness during Colorectal Cancer Awareness Month. As one of the most accessible healthcare touchpoints in the community, pharmacists are uniquely positioned to educate patients about risk factors, screening guidelines, and the importance of early detection. According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer-related deaths in the United States—yet it is highly preventable with appropriate screening.
Pharmacies can support awareness by displaying educational materials, hosting community health events, and—in some settings—facilitating access to at-home stool-based screening kits. For the month of March, CLIAwaived.com is offering free shipping with the purchase of 5 or more Test Yourself @ Home (TY@H) iFob instant test kits.
Why Colorectal Cancer Awareness Still Matters
Colorectal cancer often develops from precancerous polyps over many years. This long preclinical phase provides a valuable opportunity for detection and removal before malignancy develops.
However, screening gaps persist due to:
- Patient hesitancy or lack of awareness
- Access-to-care barriers
- Socioeconomic disparities
- Lower screening rates among younger adults
Recent trends show a concerning rise in colorectal cancer incidence among adults under 50, prompting updated screening recommendations.
Current Screening Recommendations
The U.S. Preventive Services Task Force recommends routine colorectal cancer screening beginning at age 45 for average-risk adults.
Screening modalities include:
- Colonoscopy (every 10 years if normal)
- FIT (annually)
- Stool DNA testing
- CT colonography
- Flexible sigmoidoscopy
For high-risk patients—those with family history, inflammatory bowel disease, or genetic syndromes such as Lynch syndrome—earlier and more frequent screening is advised.
Healthcare providers should ensure individualized risk assessments are incorporated into routine care.
The Role of Primary Care and Preventive Medicine
Primary care clinicians are often the first line of defense. Strategies to increase screening uptake include:
- EMR prompts and reminder systems
- Opportunistic screening discussions during annual visits
- Patient education on non-invasive options
- Addressing misconceptions about preparation and procedure discomfort
- Streamlining referral pathways to gastroenterology
Additionally, engaging patients in shared decision-making improves adherence and follow-through.
Early Symptoms: When to Investigate
While screening is ideal before symptoms arise, providers should maintain vigilance for warning signs:
- Rectal bleeding
- Unexplained iron-deficiency anemia
- Persistent change in bowel habits
- Abdominal pain or unexplained weight loss
Timely diagnostic colonoscopy remains essential when red-flag symptoms are present.
Equity in Colorectal Cancer Care
Disparities in colorectal cancer incidence and mortality persist, particularly among Black Americans and underserved populations. Addressing structural barriers, improving community outreach, and implementing culturally competent education initiatives are essential to closing these gaps.
Healthcare systems should consider:
- Community screening programs
- At-home screening kits
- Navigation services
- Language-access resources
Moving Forward: A Call to Action
Colorectal Cancer Awareness Month is more than a campaign—it is an opportunity for healthcare professionals to renew commitment to preventive care.
With effective screening tools, evidence-based guidelines, and proactive patient engagement, colorectal cancer is one of the most preventable malignancies we face today.
By prioritizing early detection and addressing barriers to care, we can significantly reduce morbidity and mortality—and ultimately save lives.
